文献速递免疫规划传染病防控与疫情报告

减毒天花疫苗候选株(KVAC103)在小鼠中有效诱导保护性免疫应答

Live attenuated smallpox vaccine candidate (KVAC103) efficiently induces protective immune responses in mice.
PubMed 文献 · Vaccine · 2024-02-02

本研究评估减毒天花疫苗候选株KVAC103不同剂量、接种次数和途径的细胞与体液免疫应答,并与CJ-50300疫苗比较,同时用VACV-WR株攻击评估保护力。结果显示二次接种后结合与中和抗体滴度呈浓度依赖性升高,中和抗体滴度高于单次注射,T细胞免疫应答在第二次接种后高于CJ-50300首次接种后。肌内、皮下和皮内接种KVAC103各组中和抗体滴度和抗原特异性IgG水平相当。VACV-WR攻击后,接种CJ-50300或KVAC103的小鼠均100%存活。

要点

  • 二次接种KVAC103后结合与中和抗体滴度呈浓度依赖性升高。
  • 第二次接种后中和抗体滴度高于单次注射后。
  • VACV-WR攻击后接种CJ-50300或KVAC103的小鼠均100%存活。

核心结论

  • KVAC103可能是能有效诱导体液和细胞免疫、保护小鼠抵抗VACV-WR株的强效天花疫苗。

研究设计与样本

  • 研究评估KVAC103不同剂量、接种次数和途径的细胞与体液免疫应答,并与CJ-50300疫苗比较,同时用VACV-WR株攻击评估保护力。
  • 原文未报告样本量。

主要发现

  • 第二次接种后结合与中和抗体滴度呈浓度依赖性升高,中和抗体滴度高于单次注射后。
  • 第二次接种后T细胞免疫应答(干扰素-γ阳性细胞)高于CJ-50300首次接种后。
  • 肌内、皮下和皮内接种KVAC103各组中和抗体滴度和抗原特异性IgG水平相当。
  • VACV-WR株攻击后,接种CJ-50300或KVAC103的小鼠均100%存活。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Smallpox, caused by the variola virus belonging to the genus Orthopoxvirus, is an acute contagious disease that killed 300 million people in the 20th century. Since it was declared to be eradicated and the national immunization program against it was stopped, the variola virus has become a prospective bio-weapon. It is necessary to develop a safe vaccine that protects people from terrorism using this biological weapon and that can be administered to immunocompromised people. Our previous study reported on the development of an attenuated smallpox vaccine (KVAC103). This study evaluated cellular and humoral immune responses to various doses, frequencies, and routes of administration of the KVAC103 strain, compared to CJ-50300 vaccine, and its protective ability against the wild-type vaccinia virus Western Reserve (VACV-WR) strain was evaluated. The binding and neutralizing-antibody titers increased in a concentration-dependent manner in the second inoculation, which increased the neutralizing-antibody titer compared to those after the single injection. In contrast, the T-cell immune response (interferon-gamma positive cells) increased after the second inoculation compared to that of CJ-50300 after the first inoculation. Neutralizing-antibody titers and antigen-specific IgG levels were comparable in all groups administered KVAC103 intramuscularly, subcutaneously, and intradermally. In a protective immunity test using the VACV-WR strain, all mice vaccinated with CJ-50300 or KVAC103 showed 100% survival. KVAC103 could be a potent smallpox vaccine that efficiently induces humoral and cellular immune responses to protect mice against the VACV-WR strain.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Hwang YH, Byeon Y, Ahn SH, et al. Live attenuated smallpox vaccine candidate (KVAC103) efficiently induces protective immune responses in mice. Vaccine. 2024. PMID: 38310019. doi:10.1016/j.vaccine.2024.01.064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。